Review: taking Lexapro and Topamax together


Summary

Drug interactions are reported among people who take Lexapro and Topamax together. This review analyzes the effectiveness and drug interactions between Lexapro and Topamax. It is created by eHealthMe based on reports of 1,686 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Lexapro and Topamax >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lexapro

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. (latest outcomes from Lexapro 44,435 users)

Topamax

Topamax has active ingredients of topiramate. It is often used in migraine. (latest outcomes from Topamax 28,047 users)

On Aug, 26, 2016

1,686 people who take Lexapro, Topamax are studied.


Number of reports submitted per year:

Lexapro and Topamax drug interactions.

Drug effectiveness over time:

Lexapro:
  • < 1 month: 28.0% - (2 of 7 people)
  • 1 - 6 months: 16.0% - (3 of 18 people)
  • 6 - 12 months: 25.0% - (3 of 12 people)
  • 1 - 2 years: 33.0% - (5 of 15 people)
  • 2 - 5 years: 47.0% - (16 of 34 people)
  • 5 - 10 years: 70.0% - (12 of 17 people)
  • 10+ years: 36.0% - (4 of 11 people)
  • not specified: 0.0% - (0 of 1 people)
Topamax:
  • < 1 month: 16.0% - (1 of 6 people)
  • 1 - 6 months: 47.0% - (11 of 23 people)
  • 6 - 12 months: 33.0% - (5 of 15 people)
  • 1 - 2 years: 28.0% - (4 of 14 people)
  • 2 - 5 years: 48.0% - (13 of 27 people)
  • 5 - 10 years: 68.0% - (11 of 16 people)
  • 10+ years: 62.0% - (5 of 8 people)
  • not specified: 100.0% - (1 of 1 people)

Drug effectiveness by gender:

Lexapro:
  • female: 42.0% - (43 of 101 people)
  • male: 14.0% - (2 of 14 people)
Topamax:
  • female: 47.0% - (47 of 98 people)
  • male: 33.0% - (4 of 12 people)

Drug effectiveness by age:

Lexapro:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 3 people)
  • 20-29: 36.0% - (8 of 22 people)
  • 30-39: 31.0% - (10 of 32 people)
  • 40-49: 37.0% - (14 of 37 people)
  • 50-59: 64.0% - (11 of 17 people)
  • 60+: 50.0% - (2 of 4 people)
Topamax:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 60.0% - (3 of 5 people)
  • 20-29: 57.0% - (11 of 19 people)
  • 30-39: 58.0% - (17 of 29 people)
  • 40-49: 37.0% - (14 of 37 people)
  • 50-59: 37.0% - (6 of 16 people)
  • 60+: 0.0% - (0 of 4 people)

Most common drug interactions over time *:

< 1 month:
  • hepatitis cholestatic
  • grand mal convulsion
  • leukopenia
  • overdose
  • somnolence
  • depression
  • fatigue
  • nausea
  • suicidal ideation
  • weight increased
1 - 6 months:
  • depression
  • suicidal ideation
  • grand mal convulsion
  • leukopenia
  • nausea
  • dizziness
  • overdose
  • tremor
  • occipital neuralgia
  • type 2 diabetes mellitus
6 - 12 months:
  • drug toxicity
  • growth retardation
  • hypospadias
  • overdose
  • suicide attempt
  • agitation
  • sleepiness
  • somnolence
  • thrombocytopenia
  • aggression
1 - 2 years:
  • anxiety
  • convulsion
  • pain
  • depression
  • obesity
  • sleep apnoea syndrome
  • type 2 diabetes mellitus
  • chest pain
  • vomiting
  • acute respiratory failure
2 - 5 years:
  • vitamin d deficiency
  • anxiety
  • depression
  • dizziness
  • basilar migraine
  • deep vein thrombosis
  • head injury
  • occipital neuralgia
  • pulmonary embolism
  • abdominal pain upper
5 - 10 years:
  • emotional distress
  • premature delivery
  • chorioamnionitis
  • maternal exposure during pregnancy
  • bipolar disorder
  • choking
  • pulmonary embolism
  • attention deficit/hyperactivity disorder
  • bronchopulmonary dysplasia
  • cleft lip and palate
10+ years:
  • akathisia
  • breast cancer female
  • enuresis
  • impairment of speech
  • memory impairment
  • short-term memory loss
  • teeth grinding and clenching
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • folliculitis
  • sleepy
not specified:
  • pain
  • nausea
  • depression
  • anxiety
  • diabetes mellitus
  • headache
  • dizziness
  • weight increased
  • fatigue
  • type 2 diabetes mellitus

Most common drug interactions by gender *:

female:
  • pain
  • depression
  • nausea
  • anxiety
  • dizziness
  • diabetes mellitus
  • headache
  • type 2 diabetes mellitus
  • weight increased
  • fatigue
male:
  • diabetes mellitus
  • anxiety
  • suicidal ideation
  • convulsion
  • pain
  • nausea
  • depression
  • type 2 diabetes mellitus
  • overdose
  • dyspnoea

Most common drug interactions by age *:

0-1:
  • drug exposure during pregnancy
  • drug exposure via breast milk
  • feeding disorder neonatal
  • abdominal pain
  • abscess
  • anaemia
  • atrial septal defect
  • cardiac failure congestive
  • chromosomal deletion
  • clostridium difficile colitis
2-9:
  • drug exposure via breast milk
  • feeding disorder neonatal
  • sedation
10-19:
  • suicide attempt
  • depression
  • convulsion
  • anxiety
  • bradycardia
  • abdominal pain
  • affective disorder
  • aggression
  • dizziness
  • drug dependence
20-29:
  • pain
  • abdominal pain
  • dyspnoea
  • headache
  • abdominal pain upper
  • nausea
  • weight increased
  • anxiety
  • urinary tract infection
  • diabetes mellitus
30-39:
  • depression
  • anxiety
  • pain
  • convulsion
  • diabetes mellitus
  • type 2 diabetes mellitus
  • headache
  • nausea
  • dyspnoea
  • pulmonary embolism
40-49:
  • type 2 diabetes mellitus
  • diabetes mellitus
  • depression
  • pain
  • nausea
  • back pain
  • anxiety
  • headache
  • fall
  • dizziness
50-59:
  • depression
  • nausea
  • fatigue
  • diabetes mellitus
  • anxiety
  • weight increased
  • drug ineffective
  • suicidal ideation
  • convulsion
  • type 2 diabetes mellitus
60+:
  • pain
  • anxiety
  • nausea
  • asthenia
  • cardiac arrest
  • impaired healing
  • rib fracture
  • tooth disorder
  • oedema peripheral
  • rash

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lexapro and Topamax?

Can you answer these questions?

More questions for: Lexapro, Topamax

You may be interested in these reviews

More reviews for: Lexapro, Topamax

On eHealthMe, Lexapro (escitalopram oxalate) is often used to treat depression. Topamax (topiramate) is often used to treat migraine. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.